SCHEMBL7567700

SCHEMBL7567700

O=C(CCc1ccc(O)c(O)c1)Oc1c(F)c(F)c(F)c(F)c1F

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 2/20 0.59
IAPP P10997 3/20 0.54
YWHAG P61981 1/20 0.48
CYP19A1 P11511 1/20 0.48
TYR P14679 1/20 0.48
MAPT P10636 3/20 0.45
KDM4E B2RXH2 2/20 0.45
ALDH1A1 P00352 2/20 0.45
HIF1A Q16665 2/20 0.45
HSD17B10 Q99714 2/20 0.45
LMNA P02545 1/20 0.45
HPGD P15428 1/20 0.45
PTGS1 P23219 1/20 0.45
BLM P54132 1/20 0.45
ALOX15 P16050 2/20 0.44
IGF1R P08069 1/20 0.44
LCK P06239 1/20 0.44
ERCC1 P07992 1/20 0.43
ERCC4 Q92889 1/20 0.43
ALOX5 P09917 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29116446 0.80 APP (0.64) APPIAPPYWHAGCYP19A1TYR
SCHEMBL3274537 0.79 APP (0.68) APPIAPPYWHAGCYP19A1TYR
SCHEMBL22499185 0.78 TDP1 (0.58) MAPTKDM4EALDH1A1ALOX5TSHR
SCHEMBL30291871 0.76 APP (0.73) APPIAPPYWHAGCYP19A1TYR
SCHEMBL490911 0.76 APP (0.73) APPIAPPYWHAGCYP19A1TYR
SCHEMBL27329952 0.76 FOLH1 (0.46) APPHIF1AMAPK1
SCHEMBL24710236 0.76 MEN1 (0.43) CYP19A1TYRMAPTKDM4EALDH1A1
SCHEMBL4965775 0.76 APP (0.68) APPIAPPYWHAGCYP19A1TYR
SCHEMBL17754343 0.75 APP (0.62) APPIAPPYWHAGCYP19A1TYR
SCHEMBL175651 0.75 APP (0.57) APPIAPPYWHAGCYP19A1TYR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0809493-B1 A METHOD FOR THE TREATMENT OF HYPERPROLIFERATIVE EPITHELIAL SKIN DISEASES BY TOPICAL APPLICATION OF HYDROXYLATED AROMATIC PROTEIN CROSS-LINKING COMPOUNDS US HEALTH (US) 2002-09-11 EP disclosed
EP-0809493-A1 A METHOD FOR THE TREATMENT OF HYPERPROLIFERATIVE EPITHELIAL SKIN DISEASES BY TOPICAL APPLICATION OF HYDROXYLATED AROMATIC PROTEIN CROSS-LINKING COMPOUNDS THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1997-12-03 EP disclosed
US-5610185-A Method for the treatment of hyperproliferative epithelial skin diseases by topical application of hydroxylated aromatic protein cross-linking compounds THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1997-03-11 US disclosed
WO-1996025159-A1 A METHOD FOR THE TREATMENT OF HYPERPROLIFERATIVE EPITHELIAL SKIN DISEASES BY TOPICAL APPLICATION OF HYDROXYLATED AROMATIC PROTEIN CROSS-LINKING COMPOUNDS THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1996-08-22 WO disclosed